Comparison of the efficacy and safety of loratadine, terfenadine, and placebo in the treatment of seasonal allergic rhinitis. 1988

A Gutkowski, and P Bedard, and J Del Carpio, and J Hebert, and M Prevost, and J Schulz, and Y Turenne, and C Yeadon
Division of Immunology and Rheumatology, St. Mary's Hospital, Montreal, Quebec, Canada.

The efficacy and safety of loratadine, 40 mg once daily, were compared with terfenadine, 60 mg twice daily, and placebo in controlling symptoms of ragweed hay fever. The study was a randomized, multicentric, parallel-group, double-blind design involving 280 patients divided into three groups receiving either loratadine, terfenadine, or placebo for a period of 14 days in the autumn of 1984. Both loratadine and terfenadine demonstrated a statistically greater reduction in symptom score compared to placebo. They were not statistically different from each other, and there was no statistical difference in the incidence of side effects between the two drugs.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003533 Cyproheptadine A serotonin antagonist and a histamine H1 blocker used as antipruritic, appetite stimulant, antiallergic, and for the post-gastrectomy dumping syndrome, etc. Antergan,Dihexazin,Periactin,Peritol,Viternum
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006255 Rhinitis, Allergic, Seasonal Allergic rhinitis that occurs at the same time every year. It is characterized by acute CONJUNCTIVITIS with lacrimation and ITCHING, and regarded as an allergic condition triggered by specific ALLERGENS. Hay Fever,Pollen Allergy,Pollinosis,Seasonal Allergic Rhinitis,Hayfever,Allergic Rhinitides, Seasonal,Allergic Rhinitis, Seasonal,Allergies, Pollen,Allergy, Pollen,Fever, Hay,Pollen Allergies,Pollinoses,Rhinitides, Seasonal Allergic,Rhinitis, Seasonal Allergic,Seasonal Allergic Rhinitides
D006634 Histamine H1 Antagonists Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. Antihistamines, Classical,Antihistaminics, Classical,Antihistaminics, H1,Histamine H1 Antagonist,Histamine H1 Receptor Antagonist,Histamine H1 Receptor Antagonists,Histamine H1 Receptor Blockaders,Antagonists, Histamine H1,Antagonists, Histamine H1 Receptor,Antihistamines, Sedating,Blockaders, Histamine H1 Receptor,First Generation H1 Antagonists,H1 Receptor Blockaders,Histamine H1 Blockers,Receptor Blockaders, H1,Antagonist, Histamine H1,Classical Antihistamines,Classical Antihistaminics,H1 Antagonist, Histamine,H1 Antagonists, Histamine,H1 Antihistaminics,Sedating Antihistamines

Related Publications

A Gutkowski, and P Bedard, and J Del Carpio, and J Hebert, and M Prevost, and J Schulz, and Y Turenne, and C Yeadon
January 1988, Arzneimittel-Forschung,
A Gutkowski, and P Bedard, and J Del Carpio, and J Hebert, and M Prevost, and J Schulz, and Y Turenne, and C Yeadon
September 1994, Annals of allergy,
A Gutkowski, and P Bedard, and J Del Carpio, and J Hebert, and M Prevost, and J Schulz, and Y Turenne, and C Yeadon
May 1998, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery,
A Gutkowski, and P Bedard, and J Del Carpio, and J Hebert, and M Prevost, and J Schulz, and Y Turenne, and C Yeadon
January 1989, The Journal of international medical research,
A Gutkowski, and P Bedard, and J Del Carpio, and J Hebert, and M Prevost, and J Schulz, and Y Turenne, and C Yeadon
January 1994, Otolaryngologia polska = The Polish otolaryngology,
A Gutkowski, and P Bedard, and J Del Carpio, and J Hebert, and M Prevost, and J Schulz, and Y Turenne, and C Yeadon
May 1993, Annals of allergy,
A Gutkowski, and P Bedard, and J Del Carpio, and J Hebert, and M Prevost, and J Schulz, and Y Turenne, and C Yeadon
July 1998, American journal of therapeutics,
A Gutkowski, and P Bedard, and J Del Carpio, and J Hebert, and M Prevost, and J Schulz, and Y Turenne, and C Yeadon
October 1989, Arzneimittel-Forschung,
A Gutkowski, and P Bedard, and J Del Carpio, and J Hebert, and M Prevost, and J Schulz, and Y Turenne, and C Yeadon
October 1989, Annals of allergy,
A Gutkowski, and P Bedard, and J Del Carpio, and J Hebert, and M Prevost, and J Schulz, and Y Turenne, and C Yeadon
January 1986, The Journal of international medical research,
Copied contents to your clipboard!